Past PSI Events

Conferences

Health Technology Assessment (HTA) Training Course

Novotel, Heathrow Airport, UK

Presented by
Mark Sculpher, Neil Hawkins 
and members of the HTA SIG

This 2-day course will provide an introduction to the methods of health technology assessment.  There will be a focus on how to estimate the costs and benefits of new interventions and analysis undertaken to support decisions about whether new interventions should be funded by health systems.  The first day will include sessions on policy context and basic economic evaluation methods, as well as lectures on health measurement and valuation for HTA, evidence synthesis and decision analysis.  There will also be exercises to confirm participants’ understanding of key concepts. The second day will focus on sharing case studies and discussing key statistical challenges in HTA.  Attendees will be encouraged to share their own HTA experiences.  

The following topics will be covered:
• HTA Policy
• Methods of economic evaluation
• Critical review of HTA publications
• Evidence synthesis
• Measuring and valuing health
• HTA decision models
• Industry HTA case studies
• Key statistical challenges in HTA

Course runs from: 10:00 – 18:00 (registration from 9:30) on Day 1 
    09:00 – 15:30 on Day 2.
 
Registration
Before 23rd December 2016
 PSI Members  £495 + VAT
 Non- Members  £570 + VAT (includes PSI membership for 1 year)

After 23rd December 2016
 PSI Members £595 +VAT 
 Non - Members £670 + VAT (includes PSI membership for 1 year) 
Registration costs (includes lunch and refreshments)

PSI are holding a limited number of hotel rooms at an extra cost until the 23rd December 2016 which will be allocated on a first come first served basis.  Please contact the PSI Secretariat for more information.

Registration is now closed.  Please contact the PSI Secretariat for late registrations.

Scientific Meetings

Health Technology Assessment (HTA) Training Course

Novotel, Heathrow Airport, UK

Presented by
Mark Sculpher, Neil Hawkins 
and members of the HTA SIG

This 2-day course will provide an introduction to the methods of health technology assessment.  There will be a focus on how to estimate the costs and benefits of new interventions and analysis undertaken to support decisions about whether new interventions should be funded by health systems.  The first day will include sessions on policy context and basic economic evaluation methods, as well as lectures on health measurement and valuation for HTA, evidence synthesis and decision analysis.  There will also be exercises to confirm participants’ understanding of key concepts. The second day will focus on sharing case studies and discussing key statistical challenges in HTA.  Attendees will be encouraged to share their own HTA experiences.  

The following topics will be covered:
• HTA Policy
• Methods of economic evaluation
• Critical review of HTA publications
• Evidence synthesis
• Measuring and valuing health
• HTA decision models
• Industry HTA case studies
• Key statistical challenges in HTA

Course runs from: 10:00 – 18:00 (registration from 9:30) on Day 1 
    09:00 – 15:30 on Day 2.
 
Registration
Before 23rd December 2016
 PSI Members  £495 + VAT
 Non- Members  £570 + VAT (includes PSI membership for 1 year)

After 23rd December 2016
 PSI Members £595 +VAT 
 Non - Members £670 + VAT (includes PSI membership for 1 year) 
Registration costs (includes lunch and refreshments)

PSI are holding a limited number of hotel rooms at an extra cost until the 23rd December 2016 which will be allocated on a first come first served basis.  Please contact the PSI Secretariat for more information.

Registration is now closed.  Please contact the PSI Secretariat for late registrations.

Training Courses

Health Technology Assessment (HTA) Training Course

Novotel, Heathrow Airport, UK

Presented by
Mark Sculpher, Neil Hawkins 
and members of the HTA SIG

This 2-day course will provide an introduction to the methods of health technology assessment.  There will be a focus on how to estimate the costs and benefits of new interventions and analysis undertaken to support decisions about whether new interventions should be funded by health systems.  The first day will include sessions on policy context and basic economic evaluation methods, as well as lectures on health measurement and valuation for HTA, evidence synthesis and decision analysis.  There will also be exercises to confirm participants’ understanding of key concepts. The second day will focus on sharing case studies and discussing key statistical challenges in HTA.  Attendees will be encouraged to share their own HTA experiences.  

The following topics will be covered:
• HTA Policy
• Methods of economic evaluation
• Critical review of HTA publications
• Evidence synthesis
• Measuring and valuing health
• HTA decision models
• Industry HTA case studies
• Key statistical challenges in HTA

Course runs from: 10:00 – 18:00 (registration from 9:30) on Day 1 
    09:00 – 15:30 on Day 2.
 
Registration
Before 23rd December 2016
 PSI Members  £495 + VAT
 Non- Members  £570 + VAT (includes PSI membership for 1 year)

After 23rd December 2016
 PSI Members £595 +VAT 
 Non - Members £670 + VAT (includes PSI membership for 1 year) 
Registration costs (includes lunch and refreshments)

PSI are holding a limited number of hotel rooms at an extra cost until the 23rd December 2016 which will be allocated on a first come first served basis.  Please contact the PSI Secretariat for more information.

Registration is now closed.  Please contact the PSI Secretariat for late registrations.

Journal Club

Health Technology Assessment (HTA) Training Course

Novotel, Heathrow Airport, UK

Presented by
Mark Sculpher, Neil Hawkins 
and members of the HTA SIG

This 2-day course will provide an introduction to the methods of health technology assessment.  There will be a focus on how to estimate the costs and benefits of new interventions and analysis undertaken to support decisions about whether new interventions should be funded by health systems.  The first day will include sessions on policy context and basic economic evaluation methods, as well as lectures on health measurement and valuation for HTA, evidence synthesis and decision analysis.  There will also be exercises to confirm participants’ understanding of key concepts. The second day will focus on sharing case studies and discussing key statistical challenges in HTA.  Attendees will be encouraged to share their own HTA experiences.  

The following topics will be covered:
• HTA Policy
• Methods of economic evaluation
• Critical review of HTA publications
• Evidence synthesis
• Measuring and valuing health
• HTA decision models
• Industry HTA case studies
• Key statistical challenges in HTA

Course runs from: 10:00 – 18:00 (registration from 9:30) on Day 1 
    09:00 – 15:30 on Day 2.
 
Registration
Before 23rd December 2016
 PSI Members  £495 + VAT
 Non- Members  £570 + VAT (includes PSI membership for 1 year)

After 23rd December 2016
 PSI Members £595 +VAT 
 Non - Members £670 + VAT (includes PSI membership for 1 year) 
Registration costs (includes lunch and refreshments)

PSI are holding a limited number of hotel rooms at an extra cost until the 23rd December 2016 which will be allocated on a first come first served basis.  Please contact the PSI Secretariat for more information.

Registration is now closed.  Please contact the PSI Secretariat for late registrations.

Webinars

Health Technology Assessment (HTA) Training Course

Novotel, Heathrow Airport, UK

Presented by
Mark Sculpher, Neil Hawkins 
and members of the HTA SIG

This 2-day course will provide an introduction to the methods of health technology assessment.  There will be a focus on how to estimate the costs and benefits of new interventions and analysis undertaken to support decisions about whether new interventions should be funded by health systems.  The first day will include sessions on policy context and basic economic evaluation methods, as well as lectures on health measurement and valuation for HTA, evidence synthesis and decision analysis.  There will also be exercises to confirm participants’ understanding of key concepts. The second day will focus on sharing case studies and discussing key statistical challenges in HTA.  Attendees will be encouraged to share their own HTA experiences.  

The following topics will be covered:
• HTA Policy
• Methods of economic evaluation
• Critical review of HTA publications
• Evidence synthesis
• Measuring and valuing health
• HTA decision models
• Industry HTA case studies
• Key statistical challenges in HTA

Course runs from: 10:00 – 18:00 (registration from 9:30) on Day 1 
    09:00 – 15:30 on Day 2.
 
Registration
Before 23rd December 2016
 PSI Members  £495 + VAT
 Non- Members  £570 + VAT (includes PSI membership for 1 year)

After 23rd December 2016
 PSI Members £595 +VAT 
 Non - Members £670 + VAT (includes PSI membership for 1 year) 
Registration costs (includes lunch and refreshments)

PSI are holding a limited number of hotel rooms at an extra cost until the 23rd December 2016 which will be allocated on a first come first served basis.  Please contact the PSI Secretariat for more information.

Registration is now closed.  Please contact the PSI Secretariat for late registrations.

Careers Meetings

Health Technology Assessment (HTA) Training Course

Novotel, Heathrow Airport, UK

Presented by
Mark Sculpher, Neil Hawkins 
and members of the HTA SIG

This 2-day course will provide an introduction to the methods of health technology assessment.  There will be a focus on how to estimate the costs and benefits of new interventions and analysis undertaken to support decisions about whether new interventions should be funded by health systems.  The first day will include sessions on policy context and basic economic evaluation methods, as well as lectures on health measurement and valuation for HTA, evidence synthesis and decision analysis.  There will also be exercises to confirm participants’ understanding of key concepts. The second day will focus on sharing case studies and discussing key statistical challenges in HTA.  Attendees will be encouraged to share their own HTA experiences.  

The following topics will be covered:
• HTA Policy
• Methods of economic evaluation
• Critical review of HTA publications
• Evidence synthesis
• Measuring and valuing health
• HTA decision models
• Industry HTA case studies
• Key statistical challenges in HTA

Course runs from: 10:00 – 18:00 (registration from 9:30) on Day 1 
    09:00 – 15:30 on Day 2.
 
Registration
Before 23rd December 2016
 PSI Members  £495 + VAT
 Non- Members  £570 + VAT (includes PSI membership for 1 year)

After 23rd December 2016
 PSI Members £595 +VAT 
 Non - Members £670 + VAT (includes PSI membership for 1 year) 
Registration costs (includes lunch and refreshments)

PSI are holding a limited number of hotel rooms at an extra cost until the 23rd December 2016 which will be allocated on a first come first served basis.  Please contact the PSI Secretariat for more information.

Registration is now closed.  Please contact the PSI Secretariat for late registrations.

Upcoming Events

PSI Introduction to Industry Training (ITIT) Course - 2026/2027

An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.

PSI Career Young Virtual Event (Q1 2026)

This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.

Inclusive and Impactful Conference Contributions

This webinar brings together three bitesize complementary sessions to help PSI contributors create conference presentations and posters that communicate clearly and inclusively. Participants will explore how to refine their message, prepare materials effectively, and adopt practical habits that support confident, accessible delivery. A focused, supportive session designed to elevate every contribution.

AIMS SIG - Open-Source Lunch Bites

Our monthly webinar series allows attendees to gain practical knowledge and skills in open-source coding and tools, with a focus on applications in the pharmaceutical industry. This month’s session, “Graphics Basics,” will introduce the fundamentals of producing graphics using the ggplot2 package.

Joint PSI/EFSPI Visualisation SIG 'Wonderful Wednesday' Webinars

Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.

Strategic role of statisticians for JCA

Join our Health Technology Assessment (HTA) European Special Interest Group (ESIG) for a webinar on the strategic role of statisticians in the Joint Clinical Assessment (JCA). The introduction of the JCA marks a new era for evidence generation and market access in Europe. As HTA requirements become more harmonized and methodologically demanding, the role of statisticians has evolved far beyond data analysis. Today, statistical expertise is central to shaping clinical development strategies, designing robust comparative evidence, and ensuring that submissions withstand the scrutiny of EU-level assessors. In this webinar, we explore how statisticians contribute strategically to successful JCA outcomes.

Statisticians in the Age of AI: On Route to Strategic Partnership

A 90-minute webinar featuring two case studies from Bayer and Roche demonstrating how statisticians successfully integrated into AI programs, followed by interactive discussion on strategies for elevating statistical expertise in the AI era.

Enhancing Clinical Study Reporting with the Estimand Framework

Join us for an insightful webinar where we explore practical strategies for applying the estimand framework in clinical study reporting. Drawing on real-world experiences and case studies, we will share recommendations to help you: • Understand the role of estimands in improving transparency and interpretation of trial results. • Navigate common challenges in implementing the framework during reporting. • Apply best practices to enhance regulatory submissions, webposting in public registries (clinicaltrials.gov/CTIS), and scientific publications. Whether you are involved in clinical trial design, data analysis, or regulatory submissions, this session will provide actionable guidance to realize the full potential of the estimand framework.

PSI Career Young Virtual Event (Q2 2026)

This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.

PSI Career Young Virtual Event (Q3 2026)

This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.

PSI Career Young Virtual Event (Q4 2026)

This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.

Latest Jobs

GSK - Statistics Director - Vaccines and Infectious Disease

We are seeking an experienced and visionary Statistics Director to join our Team and lead strategic statistical innovation across GSK’s Vaccines and Infectious Disease portfolio.

ICON PLC - Biostatistician II

We are currently seeking a Biostatistician II to join our diverse and dynamic team.

ICON PLC - Pharmacometrician

We are currently seeking a Pharmacometrician to join our diverse and dynamic team.

ICON PLC - Principal Biostatistician

As a Principal Biostatistician, you will lead the statistical strategy and delivery for Phase I–III oncology trials.

ICON PLC - Senior Biostatistician

As a Senior Biostatistician I at ICON, you will play a pivotal role in designing and analyzing clinical trials, interpreting complex medical data, and contributing to the advancement of innovative treatments and therapies.

ICON PLC - Statistical Scientist

As a Statistical Scientist at ICON, you will play a pivotal role in designing and analyzing clinical trials, interpreting complex medical data, and contributing to the advancement of innovative treatments and therapies.

Novartis - Associate Director Biostatistics

We have an exciting opportunity for an Associate Director, Biostatistics to join a passionate team within Advanced Quantitative Sciences – Full Development.

Novartis - Associate Director, Statistical Programming

: We have an exciting opportunity for an Associate Director (AD), Statistical Programming, to join a passionate team within Advanced Quantitative Sciences- Development.

Novartis - Principal Statistical Programmer

We have an exciting opportunity for a Principal Statistical Programmer, to join a passionate team within Advanced Quantitative Sciences – Development.

Novartis - Senior Principal Biostatistician

We are in search of a Senior Principal Biostatistician to join a passionate team within Advanced Quantitative Sciences.

Novartis - Senior Principal Statistical Programmer

We have an exciting opportunity for a Senior Principal Statistical Programmer, to join a passionate team within Advanced Quantitative Sciences – Development.

Pierre Fabre - Clinical Development Safety Statistics Expert M/F

We are seeking a highly skilled and proactive Clinical Development Safety Statistics Expert to join our Biometry Department and the Biometry Leadership Team based in Toulouse (31, Oncopole) or Boulogne (92).

Pierre Fabre - Lead Statistician – Real World Evidence -CDI- M/F

Pierre Fabre Laboratories are hiring a highly skilled and experienced Lead Statistician – Real World Evidence (RWE) to join the Biometry Department, part of the Data Science & Biometry Department, based in Toulouse (Oncopôle) or Boulogne.

Pierre Fabre - Lead Statistician- Clinical Trials M/F

We are seeking a highly skilled and experienced Lead Statistician in Clinical Trials to join our Biometry Department based in Toulouse (31, Oncopole) or Boulogne (92).

Plus-Project - Senior Statistician

We currently have openings for Senior Statisticians based in the UK to join our Employee Owned Biostatistics CRO, Plus-Project.

Veramed - Senior or Principal Statistician - UK/EU (Remote/ Hybrid/ Office)

We have an opportunity for an experienced high level Senior or Principal Statistician to join us on a permanent basis.

Veramed - Senior Statistical Programmer

We are looking for Senior Statistical Programmers in the UK to join Veramed, where you'll deliver high-impact programming solutions in an FSP-style capacity, while advancing your career in a supportive, growth-driven environment.